Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
复制标题
DOI:
10.3390/microorganisms9112371
复制
发表时间:
2021-11-17
期刊:
影响因子:
4.5
通讯作者:
Næss LM
中科院分区:
文献类型:
--
作者:
Julin CH;Robertson AH;Hungnes O;Tunheim G;Bekkevold T;Laake I;Aune IF;Killengreen MF;Strand TR;Rykkvin R;Dorenberg DH;Stene-Johansen K;Berg ES;Bodin JE;Oftung F;Steens A;Næss LM
We studied the secondary attack rate (SAR), risk factors, and precautionary practices of household transmission in a prospective, longitudinal study. We further compared transmission between the Alpha (B.1.1.7) variant and non-Variant of Concern (non-VOC) viruses. From May 2020 throughout April 2021, we recruited 70 confirmed COVID-19 cases with 146 household contacts. Participants donated biological samples eight times over 6 weeks and answered questionnaires. SARS-CoV-2 infection was detected by real-time RT-PCR. Whole genome sequencing and droplet digital PCR were used to establish virus variant and viral load. SARS-CoV-2 transmission occurred in 60% of the households, and the overall SAR for household contacts was 50%. The SAR was significantly higher for the Alpha variant (78%) compared with non-VOC viruses (43%) and was associated with a higher viral load. SAR was higher in household contacts aged ≥40 years (69%) than in younger contacts (40–47%), and for contacts of primary cases with loss of taste/smell. Children had lower viral loads and were more often asymptomatic than adults. Sleeping separately from the primary case reduced the risk of transmission. In conclusion, we found substantial household transmission, particularly for the Alpha variant. Precautionary practices seem to reduce SAR, but preventing household transmission may become difficult with more contagious variants, depending on vaccine use and effectiveness.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
4
作者:
Kim KB;Choi H;Lee GD;Lee J;Lee S;Kim Y;Cho SY;Lee DG;Kim M
通讯作者:
Kim M
DOI:
10.1016/j.lanepe.2020.100014
发表时间:
2021-04
期刊:
The Lancet regional health. Europe
影响因子:
--
作者:
Kuwelker K;Zhou F;Blomberg B;Lartey S;Brokstad KA;Trieu MC;Bansal A;Madsen A;Krammer F;Mohn KG;Tøndel C;Linchausen DW;Cox RJ;Langeland N;Bergen COVID-19 research group
通讯作者:
Bergen COVID-19 research group
DOI:
10.1093/infdis/jiaa691
发表时间:
2021-02-13
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Goldstein E;Lipsitch M;Cevik M
通讯作者:
Cevik M
DOI:
10.1016/s1473-3099(20)30833-1
发表时间:
2021-03
期刊:
The Lancet. Infectious diseases
影响因子:
--
作者:
Ng OT;Marimuthu K;Koh V;Pang J;Linn KZ;Sun J;De Wang L;Chia WN;Tiu C;Chan M;Ling LM;Vasoo S;Abdad MY;Chia PY;Lee TH;Lin RJ;Sadarangani SP;Chen MI;Said Z;Kurupatham L;Pung R;Wang LF;Cook AR;Leo YS;Lee VJ
通讯作者:
Lee VJ